
Journal of Organic Chemistry p. 4540 - 4549 (2016)
Update date:2022-08-03
Topics:
Lopes, Alexandra Basilio
Wagner, Patrick
De Souza, Rodrigo Octavio Mendon?a Alves
Germain, Nadège Lubin
Uziel, Jacques
Bourguignon, Jean-Jacques
Schmitt, Martine
Miranda, Leandro S. M.
C-Nucleosides are an underexplored and important class of nucleosides with antiviral and anticancer activity. In addition, triazole heterocycles are well employed as a strategy to modify nucleobase in nucleoside analogues, although rare examples were described for triazoyl C-nucleosides. N2-Aryl-1,2,3-triazole C-nucleoside compounds that could be obtained by selective 1,2,3-triazole heterocycle N2 arylation in 1-β-d-ribofuranosyl-2H-1,2,3-triazole substrate were designed in this study. The optimized condition used AdBrettPhos/[PdCl(allyl)]2 as the catalyst system. This transformation was accomplished by aryl halides bearing an electron donor and withdrawing groups, as well as by heterocyclic halides in good to excellent yields. The transformation developed in this study represents a significant contribution to the nucleoside field, once it allows for the synthesis of unexplored scaffolds through selective functionalization of triazole nucleosides.
View MoreXiamen XM-Innovation Chemical Co., Ltd
Contact:+86-592-3216205
Address:Unit Q, 11/F, No.1 Office Building, Wuyuan Bay Business Center, Huli District, Xiamen City, Fujian Province, P.R.C
Anhui Biochem United Pharmaceutical Co., Ltd.
Contact:0086 551 5167062 / 5228268
Address:No. 30 Hongfeng Road, Hi-Tech Development Zone, Hefei (230088), China
Contact:+86-371-86058576
Address:NO.32, Jingsan Road, Zhengzhou, China
Contact:
Address:
Anhui Redstar Pharmaceutical Corp., Ltd
Contact:+86-563-5120837
Address:Jingxian Industrial Development Zone, Anhui , China
Doi:10.1007/s11743-013-1490-0
(2014)Doi:10.1039/c7nj01828b
(2017)Doi:10.1021/acs.joc.9b01035
(2019)Doi:10.1002/ejoc.201601206
(2016)Doi:10.1007/s12272-012-1107-6
(2012)Doi:10.1021/jo00041a044
(1992)